Speakers - Advanced Therapies Week

Adam Mcleod

Senior Scientist • Cytiva

Aditi Singh

Global Senior Marketing Manager • Sony Biotechnology Inc

Alaina Schlinker

Senior Manager, Field Application Support Team • ScaleReady

Alex Bloom

Chief Technology Officer • AviadoBio

Alex Dahmani

Director of Business Development • Adaptive Biotechnologies

Alexandra Coelho Bras

Regulatory Affairs Specialist • Viralgen

Allen Feng

Co-Founder and Chief Scientific Officer • HebeCell Corp

Allyson Berent

Chief Science Officer • Foundation for Angelman Syndrome Therapeutics

Amit Agarwal

Managing Director • Deloitte

Amritha Jaishankar

Executive Director, Cell and Gene Therapy Center • IQVIA

Amy DuRoss

President, Cell and Gene Therapy • CSafe

Amy House

Integration & Transition Lead, Former: Senior Director, Chief of Staff to Chief Medical Officer • Gyroscope

Ana Rosa Sáez Ibáñez

Research Analyst, Clinical Accelerator and Venture Fund • Cancer Research Institute

Andreas Kouri

Senior Vice President, Supply Chain Strategic Operations • ElevateBio

Andrés Bratt-Leal

Co-Founder, Senior Vice President, Research and Development • Aspen Neuroscience

Andrew Earnshaw

Digital Health Expert • PA Consulting

Andrew Moreo

Head of Process Development • Andelyn Biosciences

Andrew Olaye

Executive Director, Market Access & Partnerships EMEA • Orchard Therapeutics

Andy Holt

Chief Commercial Officer • Cellistic

Angela Justice

Chief People Officer • TCR2 Therapeutics

Anne Cox

Director of Business Development • Tensentric

Anne Rowzee

Associate Director for Policy, Office of Tissues and Advanced Therapies • FDA

Anthony Davies

Founder & Chief Executive Officer • Dark Horse Consulting

Anthony Ting

Arnaud Deladeriere

Director of Process Development • Triumvira Immunologics

Arthur Stril

Chief Business Officer • Cellectis

Arun Das

Chief Business Officer • Cabaletta Bio

Åsa Hagner Mcwhirter

Principal Scientist • Cytiva

Becky Johnson-Kent

Vice President, Europe & Women in Advanced Therapies (WiAT) Programme Lead • Phacilitate

Benoit Bossuge

Head of Strategic Sourcing • CRISPR Therapeutics

Bernd Leistler

Vice President Production • Sartorius CellGenix

Beth Gardner

Senior Director, Patient Supply • Beam Therapeutics

Boro Dropulic

Executive Director • Caring Cross

Brad Carlin

Senior Advisor, Statistics and Data Science • PharmaLex GmbH (Biopharma excellence)

Brahm Goldstein

Vice President, Research and Development, Hematology • CSL Behring

Branden Salinas

Senior Director Manufacturing Sciences and Technology • Umoja Biopharma

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy; President, International Society for Cell & Gene Therapy • University of Pennsylvania

Bryan Poltilove

Operating Partner • Broadoak Capital Partners

Cameron Gardner

Director of Research • JURA Bio

Carl H. June

Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine • University of Pennsylvania

Cedric Ait Mansour

Global Senior Manager Market Development – New Products • Sony Biotechnology Inc

Chad Salisbury

Senior Vice President • Project Farma

Chris Brown

Head of Discovery • Metagenomi

Chris McClain

Senior Vice President of Sales and Business Development • Be The Match BioTherapies

Chris Min

Chief Executive Officer & Chief Medical Officer • Longeveron

Christian Aguilera-Sandoval

Applications Manager • Accellix

Christian Chabannon

Head of Center for Cell Therapy • GoCART Coalition

Cintia Piccina

• AdaptImmune

Courtney Horvarth

Global Head of Strategy, Planning & Operations, Translational Medicine & Childhood Cancer Advocate • Novartis

Courtney Wells

Senior Vice President, Development Operations • Talaris Therapeutics

Craig Hasilo

Cynthia Pussinen

Former Chief Technical Officer • Spark Therapeutics

Dan Kemp

President and Chief Executive Officer • Wugen

Dan Shelly

Vice President of Business Development and Alliances • Prescient Therapeutics

Dan Strange

Chief Technology Officer • Cellular Origins, A TTP Company

Daniella Kranjac

Founding Partner • Dynamk Capital

Dave Lennon

Chief Executive Officer • Satellite Bio

David Barrett

Chief Executive Officer • American Society for Gene and Cell Therapy (ASGCT)

David Chang

Chief Executive Officer • WuXi Advanced Therapies

David Hermanson

Senior Manager, CGT Applications • Bio-Techne

David Hodl

Head of Sales, Cell Therapy Custom and Configured Platforms • Invetech

David Sheehan

President & Chief Executive Officer • Nucleus Biologics

David Sourdive

Co-Founder and Executive Vice President CMC & Manufacturing • Cellectis

David Yoder

Senior Manager of Product Strategy • Aldevron

Dominic Clarke

Chief Technical Officer, Cell and Gene Therapy • Discovery Life Sciences

Don Healey

Chief Technology Officer • Adicet Bio

Donna Rill

Chief Technical Officer • Triumvira Immunologics

Emily Chee

General Manager, Americas • Novartis

Emily Titus

Senior Vice President, Technical Operations • Notch Therapeutics

Emma Bjorgum

Vice President, Client Services, DNA • Aldevron

Eric Hacherl

Vice President, Head of Manufacturing • Spark Therapeutics

Erin Leckrone

Senior Director Clinical Trials • Be The Match BioTherapies

Essra Ridha

Chief Medical Officer • AVROBIO

Eytan Abraham

Vice President & Business Head, Cell Therapy, Gene Therapy • Nucleic Acids

Fabio Fachin

Head of Cell Therapy Process Development, Automation and Digital Technologies • Takeda

Farah Speer

Senior Vice President, Corporate Communications and External Relations • AviadoBio

Faraz Ali

Chief Executive Officer • Tenaya Therapeutics

Farzin Farzaneh

Chief Scientific Officer • ViroCell Biologics

Fernanda Masri

Head of Manufacturing Innovation • Cell and Gene Therapy Catapult

Fran Gullo

Scientific Director, Gift of Life Center for Cell and Gene Therapy • Gift of Life Biologics

Frank Borriello

Chief Executive Officer • Alloplex Bio

George Buchman

Vice President, Pre-Clinical and Process Development • Catalent Cell and Gene Therapy

Glenn Lumpkin

Director of Technical Services • CAI

Gregg Nyberg

Chief Technology Officer • Landmark Bio

Gregory Fiore

Founder and Chief Executive Officer • Exacis Biotherapeutics

Gwen Binder

President, Science & Techology • Cabaletta Bio

Gwen Nichols

Chief Medical Officer • The Leukemia & Lymphoma Society

Hanna Lesch

Chief Technology Officer • Exothera

Heather Stefanski

Vice President Medical Services • Be The Match BioTherapies

Ian Gaudet

Senior Director, Site Head San Jose • Miltenyi Biotec

Ian Goodwin

Director, Global Program Design, • Fujifilm Diosynth Biotechnologies

Irina Kadiyala

Senior Director & Head, Heme Process Development • Vertex Cell and Gene Therapies

Isaac Zentner

Associate Director Process Development • Carisma Therapeutics

Ivan Wall

Professor of Regenerative Medicine • University of Birmingham

J Kelly Ganjei

President and Chief Executive Officer • AmplifyBio

Jacob Becraft

Co-Founder & CEO • Strand Therapeutics

Jacqueline Barry

Chief Clinical Officer • Cell and Gene Therapy Catapult

Jaeseung Lim

Chief Executive Officer & Chief Scientific Officer • Cellatz Therapeutics

James Kusena

Vice President, Bioprocessing & Applications • MicrofluidX

James Miskin

Chief Technical Officer • Oxford BioMedica (UK) Ltd

Jason B. Litten

Chief Medical Officer • Chimeric Therapeutics

Jean Stanton

Director, Global Cell Collection • Janssen

Jeff Liter

President and Chief Executive Officer • Luminary Therapeutics

Jeff Masten

Chief Operating Officer • Theragent

Jeffrey Boyd

Partner, Global Healthcare & Life Sciences Practice • Heidrick & Struggles

Jennifer Chow

Chief Executive Officer & Managing Director • Chimeric Therapeutics

Jennifer Collins

Principal, Apheresis and Infusion Specialist • Vertex Cell and Gene Therapies

Jennifer Fenwick

Senior Manager, Personalized Supply Chain • World Courier

Jenny Holt

Senior Vice President, Programme and Portfolio Management • Ray Therapeutics

Jenny Ligon

Associate Director, Workforce Development • National Center for Therapeutics Manufacturing (NCTM)

Jian Irish

President and Chief Operating Officer • Metagenomi

Jo Brewer

Chief Scientific Officer • AdaptImmune

John Balchunas

Workforce Director • The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

John Campbell

Director, Tissues, Cells & Advanced Therapeutics • Scottish National Blood & Transplant Service

John Lee

Senior Vice President of Cell Therapy • Center for Breakthrough Medicines

John Maslowski

Chief Commercial Officer • Forge Biologics

John Rasko

Professor • University of Sydney

Jordan Fabry

Product Specialist – Clarification Studies, Separations Technologies North America • Sartorius Stedim Biotech

Jörg Schneider

Director, Principal Consultant • BioPharma Excellence

Joy Aho

Director of Product Management • Be The Match BioTherapies

Judith Koliwer

PhD Principal Consultant, Cell & Gene Therapy • Körber Pharma Software

Julie G. Allickson

Director, Mayo Clinic Center for Regenerative Medicine & Associate Professor of Regenerative Medicine • Mayo Clinic

Julie Lenzer

Chief Innovation Officer • ARMI | BioFabUSA

Justin McCue

Chief Technical Officer • Avectas

Justin Skoble

Vice President, Head of Technical Operations • Caribou Biosciences

Karen Moniz

Technical Director • ICCBBA

Karen Walker

Chief Technical Officer • Kyverna Therapeutics

Kent Thorup

Regional Vice President • QuickSTAT Global Life Science Logistics

Kevin Ramdas

Director, Clinical Operations • Longeveron

Kim Raineri

Chief Technology Officer • Aspen Neuroscience

Kimberly Goodspeed

Assistant Professor • University of Texas Southwestern Medical Center

Kimberly Negrin

Business Unit Leader • Stoic Bio

Kinnari Patel

President & Chief Operating Officer • Rocket Pharma

Konstantina Katcheves

Senior Vice President Business Development • Bristol Myers Squibb

Kristin Viswanathan Wolff

Vice President, Market Access • bluebird bio

Kristy Shipulski

Vice President, Supply Chain Management • Vertex Cell and Gene Therapies

Lara Silverman

Founder • LIS BioConsulting

Lee Buckler

Leela Paris

Vice President, Process Engineering and Manufacturing, VCGT CMC Cell Manufacturing, • Vertex Cell and Gene Therapies

Leila Mekkaoui

Associate Director Synthetic Genomics • Autolus

Leonardo M.R. Ferreira

Assistant Professor of Microbiology and Immunology • Medical University of South Carolina

Lesley Chan

Director of Process Innovation • bluebird bio

Li Ou

Vice President • Genemagic Bio

Lili Belcastro

Senior Principal Scientist, Cell and Gene Therapy Raw Materials • Bristol Myers Squibb

Lior Raviv

Chief Technical Officer • Pluri

Lisa Deschamps

Chief Executive Officer • AviadoBio

Lisa McClain-Moss

Vice President, Manufacturing • Longeveron

Lisa Ward

Co-Founder • Tough2gether Against DIPG/DMG

Luca Alberici

General Manager, Milan Facility • AGC Biologics

Lucas De Breed

Founder • August Care

Lung-I Cheng

Vice President, Cell and Gene Therapy • AmerisourceBergen

Lydia Jordan

Principal Investigator CGT Supply Chain • GlaxoSmithKline

Lynn Fischer

Chief Executive Officer • TITLE21 Health Solutions

Maia Hansen

Chief Operating Officer • Athersys

Marc Wolfgang

Vice President of Technical Development • BioNTech

Marco Ruella

Assistant Professor of Medicine in the Division of Hematology/Oncology and the Center for Cellular Immunotherapies • University of Pennsylvania

Mark Roache

Vice President, Cell and Gene Therapies • Quality Executive Partners / Virtuosi

Mark Sawicki

President & Chief Executive Officer • Cryoport Systems

Mark Trusheim

Strategic Director, NEWDIGS Initiative Institute for Clinical Research and Health Policy Studies • Tufts Medical Center

Marlin Frechette

Chief Quality & Compliance Officer • Fujifilm Irvine Scientific

Martin Maiers

Vice President, Research • Be The Match BioTherapies

Mathias Svahn

Co-Founder • NextCell Pharma

Matt Olsen

Fluid Management Technologies Manager • Sartorius Stedim Biotech

Matthew Cato

Senior Director Cell & Gene Therapy • Mission Bio

Matthew Hewitt

Executive Director, Scientific Services, Cell and Gene Therapy • Charles River

Matthew Hewitt

Executive Director, Scientific Services, Cell & Gene Therapy (CGT) • Charles River

Matthew Lakelin

Co-Founder, Vice President of Scientific Affairs & Product Development • TrakCel

Matthew Li

Director, Cell Therapy CMC • Tome Biosciences

Matthew Toomey

Director • Merit

Mayasari Lim

Associate Director, Custom Business • Fujifilm Irvine Scientific

Meghan Verschoor

Associate Director, Data Sciences • Turnstone Bio

Melanie Rietenbach

Global Product Manager, Immunotherapy • Miltenyi Biotec

Michael Conway

Senior Director, Head of Talent Acquisition and Workforce Planning • BlueRock Therapeutics

Michael E. Meyers

Vice Chairman Head of M&A and Strategic Advisory Services • H.C. Wainwright & Co

Michael Lawlor

Professor • Medical College of Wisconsin

Michael Von Forstner

Global Head of Clinical Safety and Pharmacovigilance • Biogen

Michalle Adkins

Director, Life Sciences Strategy • Emerson

Miguel Forte

President Elect • International Society for Cell & Gene Therapy

Mike Lawlor

Professor of Pathology • Medical College of Wisconsin

Miranda Neville

Vice President Global Operations & Delivery • Autolus

Mona Jhaveri

Founder & Executive Director • Music Beats Cancer

Nadia Lounnas-Mourey

Associate Director, Process Development • Sangamo Therapeutics

Najib Rehman

Digital Automation Lead • ATMPS

Neal Flomenberg

Chief Scientific Officer • Tevogen

Nicole Paulk

Professor • University of California San Francisco

Nina Bauer

Global Head of Commercial, Biologics and Viral Vector CTDMO • MilliporeSigma

Nisha C. Durand PhD

Manager of Process Development , Human Cellular Therapy Laboratory Center for Regenerative Biotherapeutics • Mayo Clinic

Ohad Karneili

Chief Executive Officer • Adva Biotechnology

Olivia Drew

Portfolio Manager • UBS UK Life Sciences

Olivier Negre

Chief Scientific Officer • Smart-Immune

Øystein Åmellem

Director, Cell Biology • Thermo Fisher Scientific Inc

Paolo Siciliano

Cell & Gene Expert • PA Consulting

Pascal Touchon

President and Chief Executive Officer • Atara Biotherapeutics

Pete Cotter

Associate Director, Analytical Development • Verve Therapeutics

Pete Robinson

Vice President, Medical and Scientific Management, Head, Cell and Gene Therapy Consortium • Syneos Health

Peter Francis

Chief Medical Officer & Chief Scientific Officer • Ray Therapeutics

Peter Olagunju

Chief Operating Officer • TCR2 Therapeutics

Peter Peumans

Peter Walters

Fellow, Advanced Therapies • CRB

Peter Zandstra

Professor • University of British Columbia

Phil Morton

Chief Technology Officer • Albumedix

Phyllis I. Warkentin

Chief Medical Officer • Foundation for Accreditation Cellular Therapy (FACT)

Pierre Boulas

Head of Medical Devices and Packaging Development • Biogen

Piers Slater

Chief Executive • Reef Group

Priya Baraniak

Vice President Corporate Development & Head Product Development • OrganaBio

Raisa Lowe

Vice President, Head of CMC • Arbor Biotechnologies

Ram Sharma

Associate Director, Manufacturing Development • Minaris Regenerative Medicine

Ramin Baghirzade

Senior Director, Gene Therapy • Charles River

Ramona Repaczki-Jones

Executive Director, Commercial Treatment Center Operations, Cell Therapy • Iovance Biotherapeutics Inc

Rebecca Lim

Senior Vice President – Scientific Affairs • Prescient Therapeutics

Ricardo Baptista

Chief Technology Officer • Alder Therapeutics

Rob Tressler

Chief Scientific Officer • Excellos

Robert Hughes

Vice President & General Manager • Miltenyi Biotec

Robert Keefe

Chief Development Officer • BlueSphere Bio

Robert Newman

Chief Scientific Officer • Fujifilm Irvine Scientific

Roel Gordijn

Chief Commercial Officer • Polyplus

Ronit Slotky

Director, Cell Therapy Manufacturing Facility • Hackensack University Medical Center

Ryan Crisman

Chief Technical Officer • Umoja Biopharma

Ryan Leahy

Vice President of Research • Phacilitate

Ryan Saadi

Founder, Chair and Chief Executive Officer • Tevogen

Samarendra Mohanty

Co-Founder and President • Nanoscope Therapeutics

Samik Basu

Chief Scientific Officer • Cabaletta Bio

Samik Upadhaya

Assistant Director of Scientific Affairs • Cancer Research Institute

Sarah Busch

Vice President of Regenerative Medicine, Head of Nonclinical Development • Athersys

Scott Bertch

Executive Director, Clinical Site Head • Tenaya Therapeutics

Scott Gottesman

Vice President, Human Resources • AVROBIO

Scott Jones

Senior Vice President & Chief Scientific Officer • BioBridge Global

Serene Forte

Senior Vice President and Head of Genetic Medicine • RELIEF Therapeutics

Sharon Hesterlee

Executive Vice President, Chief Research Officer • Muscular Dystrophy Association USA

Shreenal Patel

Executive Vice President, Patient Supply • Achilles Therapeutics

Stefano Baila

Managing Director • Eurofins

Stefanos Theoharis

Core Team Member • Cell One Partners

Stephen Sullivan

Founder • Lindville Bio

Stephen Ward

Chief Manufacturing Officer • Cell and Gene Therapy Catapult

Steve Kanner

Chief Scientific Officer • Caribou Biosciences

Steven B. Miller

Stuart Gibb

Scientific Strategy Lead • Terumo Blood and Cell Technologies

Sujay Kango

Chief Executive Officer • Tmunity

Sumit Verma

Senior Vice President, Commercial Manufacturing • Iovance Biotherapeutics Inc

Susan B. Nichols

Chief Business Officer • ViroCell Biologics

Suyash Prasad

Chief Medical Officer and Head of Research & Development • Taysha Gene Therapies

Sven Kili

Chief Executive Officer • Antion Biosciences

Tanya Sharma

,Co-Founder • Assurea

Tay Salimullah

Vice President, Head of Global Value & Access, Novartis Gene Therapies • Novartis

Teonna Woolford

Chief Executive Officer • Sickle Cell Reproductive Health Education Directive

Tess Kitchener

Vice President BaseCamp Business Development • ElevateBio

Tessa Rowe

User Experience and Human Factors Engineering • Tensentric

Thomas Bollenbach

Chief Technology Officer • ARMI

Tiffany M. Clement

Cell Therapies Core Inventory Management & Support Services Manager • Moffitt Cancer Center

Timothy D. Hunt

Chief Executive Officer • Alliance for Regenerative Medicine

Tom Whitehead

Founder • Emily Whitehead Foundation

Tony Ward

Chief Technology Officer • Curate Biosciences

Tony Wells

CEO • Merit

Troels Jordansen

Chief Executive Officer • GlycoStem

Tunç Toker

Chief Operating Officer • Galen Therapeutics

Vincent Ling

Senior Director • Takeda

Will Rohleder

Development Director • Reef Group

William Shingler

Head of Patient and Cell Management • Autolus

Wilson Bryan

Director, Office of Tissues and Advanced Therapies • FDA

Wissam Baghdadi

Engineer Process Development • Sangamo Therapeutics

Wolfgang Künnecke

Vice President of Bioanalytics • 908 Devices

Xavier De Mollerat Du Jeu

Senior Director of Research and Development • Thermo Fisher Scientific Inc

Yara Park

Professor and Director • University of North Carolina

Yossi Schwartz

Professor, Pathology, Molecular and Cell Based Medicine at the Icahn School of Medicine • Mount Sinai Health System

Zankar Desai

Assistant Technical Director, Cell Therapy Testing Lab • Dana-Farber Cancer Institute

Zhimei Du

Vice President, Translational Research and Early Development • Landmark Bio

2023 Speakers